FATE THERAPEUTICS INC Preferred Stock, Shares Outstanding
FATE THERAPEUTICS INC (FATE) had Preferred Stock, Shares Outstanding of 2.76 million shares as of 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Balance Sheet › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2024-08-13
- 2024-06-30: Preferred Stock, Shares Outstanding 2.76M shares.
- 2023-12-31: Preferred Stock, Shares Outstanding 2.76M shares.
- 2016-09-30: Preferred Stock, Shares Outstanding 0.00 shares.
- 2016-06-30: Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2024-06-30 | 2.76M shares 10-Q · filed 2024-08-13 |
| 2023-12-31 | 2.76M shares 10-Q · filed 2024-08-13 |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-07 |
| 2016-06-30 | 0.00 shares 10-Q · filed 2016-08-08 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-09 |
| 2015-12-31 | 0.00 shares 10-Q · filed 2016-11-07 |
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-03 |
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-05 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-07 |
| 2014-12-31 | 0.00 shares 10-K · filed 2016-03-03 |
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-11-12 |
| 2014-06-30 | 0.00 shares 10-Q · filed 2014-08-12 |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-13 |
| 2013-12-31 | 0.00 shares 10-K · filed 2015-03-12 |
| 2012-12-31 | 0.00 shares 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |